INTRODUCTION
The generation of isoprenoids from acetyl-CoA is an important metabolic pathway whose products include cholesterol, dolichols and ubiquinones [1] . Recently, evidence has accumulated that some proteins are post-translationally modified by isoprenylation [1] [2] [3] [4] [5] . The isoprenylated proteins which have been identified include the yeast mating factor a, the nuclear lamin B, the ysubunits of transducin and of other heterotrimeric G-proteins in brain, cyclic GMP phosphodiesterase, rhodopsin kinase, and, especially, the small-molecular-mass (20-28 kDa) GTP-binding proteins (SMGs) [1] [2] [3] [4] [5] [6] [7] . The latter include the ras family and rasrelated SMGs, such as rac, rap, ral and rab [1] [2] [3] [4] [5] . These proteins (except rab) have a CAAX sequence at their C-terminus (C stands for cysteine, A is an aliphatic amino acid and X is any amino acid). It was found that two polyisoprenoids, geranylgeranyl and farnesyl (depending on whether leucine is the amino acid X or not), are linked to the cysteine via thioether bonds by specific prenyl-protein transferases . rab proteins, with a CC or CXC motif at the C-terminus, are isoprenylated by distinct geranylgeranyl-protein transferase(s) [4, 5] . The isoprenylated proteins become more hydrophobic, which facilitates their association with membranes [1] [2] [3] [4] [5] 8] .
Mevalonate (MVA) is the essential precursor of all isoprenoids.
the presence of the potentiating agents forskolin or phorbol myristate acetate remained unaffected. As the modulation of insulin secretion by isoprenaline and somatostatin were not altered by lovastatin, the drug does not non-selectively affect the binding of ligands to their receptors. Lovastatin did not interfere with the activation of phospholipase C by bombesin and vasopressin, since the rise in cytosolic Ca2l induced by these agents was not changed. Limonene, proposed to block specifically prenyl-protein transferases of SMGs, did not alter protein isoprenylation patterns, but inhibited the stimulated insulin secretion. In conclusion, lovastatin selectively attenuated the potentiation of nutrient-induced insulin secretion by bombesin and vasopressin without affecting their activation of phospholipase C. The concomitant changes in SMG isoprenylation and their subcellular distribution after lovastatin treatment suggest that SMGs could play an important role in the bombesin and vasopressin action on insulin secretion.
It is generated from 3-hydroxy-3-methylglutaryl-CoA (HMGCoA) in the reaction catalysed by HMG-CoA reductase. This enzyme is under the feedback control of cholesterol and unknown non-steroid(s) [1] and can be competitively inhibited by compactin and lovastatin [9] [10] [11] . Using the HMG-CoA reductase blockers and the mutation of the C-terminal CAAX sequence of proteins, it was discovered that protein isoprenylation plays a crucial role in cell growth [5, 12] , cell transformation by ras [8] , the GTP-binding activity of transducin [13] , the NK cell killing ability [14] , the antigen-mediated signal production in basophils [15, 16] and the activity of NADPH oxidase in HL-60 cells [17] . SMGs have been found to participate in the secretion in yeast [4] and in the vesicle transport from the endoplasmic reticulum through the Golgi complex to the plasma membrane in eukaryotic cells [18] . In the present study, the possible role of SMGs in insulin secretion was examined by interfering with their isoprenylation after lovastatin treatment of HIT-Ti 5 cells. It was found that lovastatin caused a large accumulation of several SMGs in the cytosol and some decrease of these proteins in membranes. Lovastatin selectively attenuated the potentiation by bombesin and vasopressin of nutrient-induced insulin secretion, and this inhibition could be reversed by addition of MVA. The effects of nutrients, forskolin, the phorbol ester phorbol 12-myristate 13 
MATERIALS AND METHODS Materials
The sources of the materials used have been described elsewhere [19, 20] [22] . Protein content was determined as described by Lowry et al. [23] .
Insulin secretion from intact cells At 2 days after their seeding, the cells were washed twice with KRBH. Thereafter, they were preincubated for 30 min in the same glucose-free KRBH with indicated test agents at 37 'C. Subsequently, the medium was changed to one containing the various stimuli. Thereafter the cells were incubated for another 15 min. The supernatants were removed, centrifuged at 4 'C and kept at -20 'C until insulin assay. Attached cells were extracted with acid/ethanol for determination of insulin content [20] .
Insulin secretion from permeabilized cells
For streptolysin-O permeabilization [24] , cells seeded in culture plates were washed twice with Ca2+-free KRBH and once with potassium glutamate buffer [25] at room temperature. Thereafter cells were rendered permeable in the potassium glutamate buffer containing 1.5 units of streptolysin-O/ml for 5 min at 37 'C. The permeabilizing solution was removed. The buffer containing 10.2 mM EGTA and different concentrations of Ca2+ and other test agents was then added. The cells were incubated for another 5 min. The supernatants were removed and the cells extracted as mentioned above for measurement of insulin secretion and content, respectively. Insulin was measured by radioimmunoassay with rat insulin as standard [20] .
Cell permeability was examined by the Trypan Blue exclusion test. After streptolysin-O treatment, more than 95 % of the cells were permeable to the dye.
[Ca2+], measurement Cells were loaded with 1 ,M fura-2 acetoxymethyl ester for 30 min at 37 'C in RPMI 1640 medium containing 10 mM Hepes and 1 % fetal-calf serum. Cells were washed with glucose-free KRBH without BSA before their transfer into a cuvette (about 1 x 106 cells/ml). Fluorescence was measured in a fluorimeter with excitation and emission wavelengths at 340 and 505 nm respectively. Fluorescence from extracellular fura-2 was assessed by adding 100 ,uM Mn2+ at the beginning and the end of each trace [19, 20] . [Ca2+]i was calculated by using an equation as described previously [26] .
Measurement of membrane potential
After two washes, about 3 x 106 cells were placed in a cuvette containing 2 ml ofglucose-and BSA-free KRBH. The fluorescent probe bisoxonol [bis-(1 ,3-diethyl thiobarbiturate)trimethineoxonol] (100 nM) was added. Membrane potential was measured by monitoring the fluorescence at excitation and emission wavelengths of 540 and 580 nm respectively [19, 20] .
Statistics
The results are expressed as means + S.E.M. and were analysed by two-tailed unpaired Student's t test. 
RESULTS
Effect of lovastatin on cell growth, insulin and cholesterol content It has been found that lovastatin inhibits proliferation in some cell systems [5, 12] . 20 and 70 kDa ( Figure 1 ). Most of the isoprenylated proteins have not yet been identified. An isoprenylated band in the region of 70 kDa was detected, possibly corresponding to nuclear lamin B according to other studies [27, 28] . Most of the isoprenylated proteins migrated, however, with an apparent molecular mass between 20 and 27 kDa (Figure 1 ).
Effects of lovastatin on the distribution and the electrophoretic mobility of small G-proteins Several SMGs have been shown to be isoprenylated [1] [2] [3] [4] [5] and to require this post-translational modification for correct intracellular localization [1] [2] [3] [4] [5] 8] . To probe a possible role of SMGs in insulin secretion, the effect of lovastatin on the distribution of these proteins between cytosol and membranes was assessed by the GTP-overlay technique [21] . As previously reported [21] , a group of SMGs migrated in the range of [21] [22] [23] [24] [25] [26] [27] Effects of lovastatin on insulin secretion from intact HIT cells Figure 3 shows the effect of 24 dependent, with significant inhibition already seen at 6,M and maximal action at 25,M. In contrast, lovastatin did not significantly alter the potentiation caused by the cyclic-AMP-increasing agent forskolin (4-fold), to the protein kinase C activator PMA (1.7-fold), and to the /-adrenergic receptor agonist isoprenaline (1.4-fold) . Furthermore, the inhibitory action (50 %) of somatostatin on insulin secretion induced by the nutrient mixture was also unaffected by lovastatin. These results indicate that lovastatin does not interfere non-specifically with receptor activation and that it only selectively influences the action of receptor agonists which couple to PLC.
When 200 ,uM MVA was added together with 25 ,uM lovastatin during 24 h treatment of the cells, the attenuating effect of lovastatin on bombesin-potentiated insulin secretion was reversed by 88 % (Figure 3) , suggesting that the inhibitory effect of lovastatin is due to the blockade of HMG-CoA reductase.
Effects of lovastatin treatment on [Ca2+] and membrane potential
Certain y-subunits of the heterotrimeric G-proteins have been reported to be isoprenylated [13,30,3 1] . If [28] . We compared the actions of limonene and lovastatin in HIT cells. As shown in Figure 6 , treatment of cells with limonene inhibited the secretagogue-induced insulin secretion in a dose-dependent manner. However, in contrast with lovastatin, limonene exerted a general inhibitory effect, since nutrient-stimulated and forskolin-potentiated insulin secretion were also affected. In cells treated with 0.5 mM limonene, the mixed nutrient-induced insulin secretion was not affected, whereas bombesin and forskolin effects were inhibited by 14 
DISCUSSION
Nutrients such as glucose and amino acids are the main physiological initiators of insulin release. The secretion induced by these agonists can be further potentiated by hormones and neurotransmitters which generate cyclic AMP by stimulating adenylate cyclase or cause phosphatidylinositol 4,5-bisphosphate breakdown via the activation of PLC [32] . The two products of the latter reaction, Ins(1,4,5)P3 and diacylglycerol, respectively mobilize Ca2" from intracellular stores and activate protein kinase C. In the present study, we clearly demonstrate that the potentiating effect of the two PLC agonists bombesin and AVP [19, 20, 29] on nutrient-induced insulin secretion is attenuated by the blockade of HMG-CoA reductase with lovastatin. Several lines of evidence indicate that lovastatin action is selective and not the result of a non-specific toxic effect on the cells. Firstly, neither the nutrient-stimulated insulin secretion nor the influence of other receptor ligands such as isoprenaline or somatostatin was affected by lovastatin treatment. Secondly, the enhanced secretion resulting from the direct activation of protein kinase C (by PMA) or of adenylate cyclase (by forskolin) were also not significantly altered. Thirdly, in streptolysin-O-permeabilized HIT cells, insulin release triggered by GTP [S] was not affected and that by micromolar Ca2" concentrations was only weakly decreased after lovastatin treatment, indicating that the blockade of HMG-CoA reductase is not having a generalized effect on the secretory machinery. Fourthly, exogenously provided MVA, which by-passes the inhibition of HMG-CoA reductase, prevents the action of lovastatin on insulin release, pointing to the implication of MVA metabolites. The specific action of lovastatin on the signal transduction was also seen in other cells. Thus the drug inhibits the secretory and morphological responses of rat basophilic leukaemia cells to antigen, but not to ionomycin and PMA [16] . Lovastatin also selectively inhibits the signal pathways of the progressive growth factors and does not affect the competent ones [33] .
Cholesterol, a very important membrane component, is one of the metabolic products of MVA. A decrease in the amount of cholesterol would greatly change the properties of the membranes (especially the plasma membrane) and might therefore have profound effects on cell growth and exocytosis. In our study, however, the cellular cholesterol content was not altered by lovastatin treatment. This is probably due to the fact that our cells in culture can obtain cholesterol from the lipoproteins present in the culture medium, and do not therefore depend on the endogenous steroid production. Similar observations have also been reported by others [14] . MVA metabolism is essential for the cell growth, and both of its products of steroid and nonsteroid nature are needed [1] . The escape of HIT-cell growth from inhibition during 24 h lovastatin treatment might be due to the rather long half-life of the isoprenylated proteins involved. Indeed, the SMGs in membranes were only partially decreased after 24 h treatment with lovastatin. Failure of lovastatin (20 h treatment) to affect growth has also been reported for other cells [15] . The lovastatin effect on secretion and morphology could be reversed by MVA, the product of HMG-CoA reductase, pointing to the implication of its metabolites. However, steroid derivatives may not be involved, since cholesterol and dolichol did not restore the compactin-altered NK-cell-killing ability and HL-60 cell NADPH oxidase activity as well as lovastatin-induced secretory and morphological changes in basophils [14, 15, 17] .
Isoprenoids constitute another important class of MVA metabolites. In fact, recently some of these compounds, in particular farnesyl and geranylgeranyl groups, have been shown to be covalently linked to several cellular proteins [1] [2] [3] [4] [5] . The posttranslational addition of isoprenyl chains is crucial for the correct targeting of the proteins to the membranes [1] [2] [3] [4] [5] 8] . Several proteins have been reported to be isoprenylated, including the SMGs of the ras and the ras-related family [1] [2] [3] [4] [5] , the y-subunit of heterotrimeric G-proteins [13, 30, 31] and lamin B [27] . Thus, a priori, a possible explanation for the effect of lovastatin on the potentiation of insulin secretion by bombesin and AVP was the inhibition of the isoprenylation of the ysubunit of the heterotrimeric G-protein that links the receptors to PLC with a consequent uncoupling of the receptor from the phosphatidylinositol 4,5-bisphosphate breakdown. Indeed, lovastatin treatment has been reported to inhibit the antigeninduced Ins(1,4,5)P3 generation and 45Ca2+ influx and efflux in basophilic leukaemia cells [15] . This possibility was, however, ruled out, since the [Ca2+], rise induced by bombesin and AVP was not altered after the blockade of HMG-CoA reductase. Furthermore, the effects on insulin secretion of two other agonists, isoprenaline and somatostatin, whose receptors are coupled to heterotrimeric G-proteins (Gs and Gi respectively) [34, 35] , are unchanged in lovastatin-treated cells. These results indicate that, under our experimental conditions, the heterotrimeric G-proteins and, in particular, the one directly activating PLC remain functional, and suggest the involvement of a lovastatin-sensitive site beyond the generation of Ins(1,4,5)P3 and diacylglycerol in the secretory response to bombesin and AVP.
SMGs, which control a number of important cellular functions and in particular the vesicular transport between organelles [1] [2] [3] [4] [5] 8, 18] , constitute another important group of isoprenylated proteins. The farnesyl or the geranylgeranyl groups attached to the cysteines in the C-terminal region of these proteins have been demonstrated to be required for their attachment to membranes [1] [2] [3] [4] [5] 8] . Thus in HIT cells the lovastatin treatment caused inhibition of protein isoprenylation and accumulation of newly synthesized SMGs in the cytosol. The accumulation of the SMGs in the cytosol was accompanied by a partial decrease in the amount of these proteins in the membrane fraction. Their incorrect subcellular location after lovastatin treatment, together with the fact that the non-isoprenylated SMGs are unable to interact with the regulatory protein GDP-dissociation inhibitor [4] , may significantly perturb the functioning of several SMGs. Thus, although direct evidence that SMGs are involved in bombesin and AVP effects on insulin secretion is lacking, the specific action of lovastatin on the potentiation of nutrientinduced insulin release by PLC-activating ligands may be due to the incorrect post-translational processing of these proteins. Indeed, both protein kinase C and the intrinsic tyrosine kinase of some growth-factor receptors have been shown to affect the protein regulating the GTPase activity of ras [36, 37] [16] . The mechanism underlying the GTP[S] action on secretion is still not clarified. In insulin-secreting cells we have shown that poorly hydrolysable GTP analogues can trigger exocytosis via a PLCand protein kinase C-independent pathway [39] . The involvement of a G-protein directly controlling exocytosis and named GE has been postulated [40] . The identity of this protein remains, however, elusive. In any case, the G-protein controlling exocytosis in permeabilized cells is not affected by the blockade of HMG-CoA reductase during 24 h, suggesting that it does not require a post-translational isoprenylation. Alternatively the possibility remains that after 24 It has been reported that limonene specifically inhibits the isoprenylation of SMGs without effect on other highermolecular-mass proteins such as nuclear lamin in some cells [28] . This limonene effect has been proposed to be due to its inhibition of the prenyl-protein transferase specific for SMGs [28] . In our study, treatment of HIT cells for 24 [41] . Therefore, it is questionable whether limonene acts generally as a specific inhibitor of prenylprotein transferases for SMGs.
In conclusion, the blockade of MVA production by the inhibition of HMG-CoA reductase with lovastatin decreased the isoprenylation of several SMGs and altered their subcellular distribution. This treatment selectively attenuated the potentiating effect of PLC-activating agonists on insulin secretion without affecting the coupling of the receptors to phosphatidylinositol 4,5-bisphosphate breakdown. Our results point to the involvement of an isoprenylated protein, possibly belonging to the SMG family, in the potentiation of nutrient-induced insulin secretion by bombesin and AVP.
